E. Bergsland

Oncology · 2000–2007

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom E. Bergsland trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. N. Ferrara

Who trusts E. Bergsland overall

  1. N. Ferrara
  2. J. Joyce

Papers from E. Bergsland's perspective

Ordered by how strongly the researchers E. Bergsland trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Tumor angiogenesis (Advances in Cancer Research)
  2. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. (Journal of Clinical Investigation)
  3. Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis (Journal of Cell Biology)
  4. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. (Cancer Research)
  5. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
  6. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. (Seminars in Oncology)
  7. Molecular mechanisms and clinical applications of angiogenesis (Nature)
  8. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 (Nature Medicine)
  9. Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
  10. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)

Their papers